Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
about
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategiesCommon angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2bMitochondria in the pathogenesis of diabetes: a proteomic viewChromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathwaysAngiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibitionAngiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.The frail renin-angiotensin system.Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelinesGenotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors.Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling.Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.Activation of a local renin angiotensin system in podocytes by glucose.Benefits of a 12-week lifestyle modification program including diet and combined aerobic and resistance exercise on albuminuria in diabetic and non-diabetic Japanese populations.Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways.
P2860
Q24656109-1E7BDB2A-118C-4DA6-A6A4-09EC0FDF6B3AQ25257883-98E6644C-1855-4521-8D51-A0CE008C2EC0Q28394886-20C78A6F-B093-46F0-B61C-9D58DE2F6BBBQ30421709-86A8AFE6-9884-4409-B3D3-205E244E7A8CQ34408514-22C8E9A1-4873-45CF-8723-3A7DB48AB984Q34500735-D27FB325-7065-489C-AD9D-67F07CC5837EQ35050508-F1462039-9A40-49D9-A3C2-D3EB92BA073DQ36165860-70B004F0-698C-46BE-A4E5-E7746BE90C46Q36342643-87485934-F449-4013-860B-45AA27E9DAC3Q37071676-0A8E5E54-3C33-49F2-83DD-4880E96BFE74Q37150747-21125A67-2566-40B4-9179-0B32F7731FCEQ37262681-55B237BB-5EF1-4319-AAD8-5C6B80A2BC77Q40394729-C5B8083C-D4CB-4197-80CB-D5207FAD797CQ42177918-04EFCEE3-D018-44CF-9CAA-449B61388C13Q45049012-FA166540-EEC0-4979-ADB4-15851B6492C9Q46794009-10EF7076-182D-4AAF-9452-273C6995A216Q51306844-3EBDF438-BCEC-458E-A40B-C3CC02CA3021Q54441122-8CFB4C84-1C27-4814-AD4A-FC68DF78D34F
P2860
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@ast
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@en
type
label
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@ast
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@en
prefLabel
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@ast
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@en
P356
P1476
Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
@en
P2093
Edmund J Lewis
Julia B Lewis
P2888
P356
10.1007/S101570300000
P577
2003-03-01T00:00:00Z